1-3 of 3
Yu-Jing Zhang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of Radiotherapy in Patients with Refractory Hodgkin Lymphoma after Brentuximab Vedotin and -/or Immune Checkpoint Inhibitors

Ting-Bo Liu, Xiaofan Li, Rui-Zhi Zhao, Han Shao, Gui-Qing Shi, Yan-Yan Qiu, Tian-Lan Tang, Yu-Ping Lin, Si-Lin Chen, Cheng Huang, Si-Qin Liao, Jin-Hua Chen, Hai-Ying Fu, Jian-Zhi Liu, Jian-Zhen Shen, Ben-Hua Xu, Yu-jing Zhang, Yong Yang
Journal: Blood
Blood (2023) 142 (Supplement 1): 6189.
https://doi.org/10.1182/blood-2023-184773
Published: 2023
Journal Articles

PD-L1 Is up-Regulated By EBV-Driven LMP1 through NF-κb Pathway and Correlates with Poor Prognosis in Natural Killer/T-Cell Lymphoma

Xi-Wen Bi, Hua Wang, Wen-Wen Zhang, Zhongjun Xia, MD, Yu-jing Zhang, Liang Wang, MD
Journal: Blood
Blood (2016) 128 (22): 4134.
https://doi.org/10.1182/blood.V128.22.4134.4134
Published: 2016
Journal Articles

Risk-adapted therapy for early-stage extranodal nasal-type NK/T-cell lymphoma: analysis from a multicenter study

CME Clinical Trials & Observations
Yong Yang, Yuan Zhu, Jian-Zhong Cao, Yu-Jing Zhang, Li-Ming Xu, Zhi-Yong Yuan, Jun-Xin Wu, Wei Wang, Tao Wu, Bing Lu, Su-Yu Zhu, Li-Ting Qian, Fu-Quan Zhang, Xiao-Rong Hou, Ye-Xiong Li
Journal: Blood
Blood (2015) 126 (12): 1424–1432.
https://doi.org/10.1182/blood-2015-04-639336
Published: 2015
Includes: Supplemental data